Zobrazeno 1 - 10
of 253
pro vyhledávání: '"Yukio, Osaki"'
Autor:
Robert S. Brown, Jr., Michio Imawari, Namiki Izumi, Yukio Osaki, Roy Bentley, Toshimitsu Ochiai, Takeshi Kano, Markus Peck-Radosavljevic
Publikováno v:
JHEP Reports, Vol 3, Iss 2, Pp 100228- (2021)
Background & Aims: Despite limitations, platelet transfusion has been used to minimise bleeding risk in patients with thrombocytopaenia. Lusutrombopag is an oral, thrombopoietin receptor agonist approved for treatment of thrombocytopaenia associated
Externí odkaz:
https://doaj.org/article/00c94837cc9149418baab00a32c04ccc
Autor:
Steven L, Flamm, Markus, Peck-Radosavljevic, Takahiro, Fukuhara, Roy, Bentley, Takayuki, Katsube, Toshimitsu, Ochiai, Takeshi, Kano, Eri, Tsukimura, Ritsue, Sasaki, Yukio, Osaki
Publikováno v:
Advances in Therapy. 39:4285-4298
Patients with thrombocytopenia and chronic liver disease are at increased risk of bleeding during invasive procedures due to low platelet counts. Lusutrombopag, an orally active thrombopoietin receptor agonist, increases platelet count and reduces th
Autor:
Toshie Mashiba, Kouji Joko, Masayuki Kurosaki, Hironori Ochi, Yukio Osaki, Yuji Kojima, Ryo Nakata, Tohru Goto, Akahane Takehiro, Hiroyuki Kimura, Akeri Mitsuda, Chiharu Kawanami, Yasushi Uchida, Chikara Ogawa, Atsunori Kusakabe, Ryuichi Narita, Yasushi Ide, Takehiko Abe, Keiji Tsuji, Tadashi Kitamura, Kazuhiko Okada, Tetsuro Sohda, Masaya Shigeno, Takashi Satou, Namiki Izumi
Publikováno v:
PLoS ONE, Vol 13, Iss 4, p e0194704 (2018)
This study aimed to elucidate whether interferon (IFN)-free direct-acting antiviral (DAA) therapy for hepatitis C after curative treatment of hepatocellular carcinoma (HCC) promotes HCC recurrence in a real-world large-scale cohort.This multicenter s
Externí odkaz:
https://doaj.org/article/fa8946d099b443f1b37b8da73dbc579e
Autor:
Takeshi Yamashina, Takehiko Tumura, Takanori Maruo, Takayuki Matsumae, Hiroyuki Yoshida, Gensho Tanke, Mio Taki, Manabu Fukuhara, Yoshito Kimura, Azusa Sakamoto, Shinichiro Henmi, Yugo Sawai, Sumio Saito, Norihiro Nishijima, Akihiro Nasu, Hideyuki Komekado, Masanori Asada, Ryuichi Kita, Toru Kimura, Yukio Osaki
Publikováno v:
Endoscopy International Open, Vol 06, Iss 01, Pp E111-E114 (2018)
Background and study aims Rectal neuroendocrine tumors grade 1 (NET G1; carcinoid) ≤ 10 mm in diameter often extend into the submucosa, making their complete histological resection difficult using endoscopic techniques. Endoscopic submucosal resect
Externí odkaz:
https://doaj.org/article/2520e54ad9c24fd8afc9f23b166e804c
Autor:
MIYUKI SAWASAKI, HIROSHI TSUBAMOTO, AYAKO SUGIHARA, SHINICHI IKUTA, YOSHIYUKI SAKAI, YUKIO OSAKI, TAKASHI SONODA
Publikováno v:
Anticancer research. 42(12)
Combination chemotherapy with gemcitabine, nab-paclitaxel, oxaliplatin, and itraconazole (GnPO-ITC) was administered as first-line chemotherapy in patients with metastatic pancreatic cancer (mPC). The efficacy and toxicity of these treatments were re
Autor:
Takeshi Yamashina, Manabu Fukuhara, Takanori Maruo, Gensho Tanke, Saiko Marui, Ryota Sada, Mio Taki, Yoshiaki Ohara, Azusa Sakamoto, Shinichiro Henmi, Yugo Sawai, Sumio Saito, Norihiro Nishijima, Akihiro Nasu, Hideyuki Komekado, Akira Sekikawa, Masanori Asada, Takehiko Tumura, Ryuichi Kita, Toru Kimura, Yukio Osaki
Publikováno v:
Endoscopy International Open, Vol 05, Iss 07, Pp E587-E594 (2017)
Background and study aims Cold snare polypectomy (CSP) for small colorectal polyps has lower incidence of adverse events, especially delayed postpolypectomy bleeding (DPPB). However, few data are available on comparisons of the incidence of DPPB of C
Externí odkaz:
https://doaj.org/article/068a6c02c70c4facb601cf8d67e65187
Autor:
Jun Itakura, Masayuki Kurosaki, Chitomi Hasebe, Yukio Osaki, Kouji Joko, Hitoshi Yagisawa, Shinya Sakita, Hiroaki Okushin, Takashi Satou, Hiroyuki Hisai, Takehiko Abe, Keiji Tsuji, Takashi Tamada, Haruhiko Kobashi, Akeri Mitsuda, Yasushi Ide, Chikara Ogawa, Syotaro Tsuruta, Kouichi Takaguchi, Miyako Murakawa, Yasuhiro Asahina, Nobuyuki Enomoto, Namiki Izumi
Publikováno v:
PLoS ONE, Vol 11, Iss 10, p e0165339 (2016)
We aimed to clarify the characteristics of resistance-associated substitutions (RASs) after treatment failure with NS5A inhibitor, daclatasvir (DCV) in combination with NS3/4A inhibitor, asunaprevir (ASV), in patients with chronic hepatitis C virus g
Externí odkaz:
https://doaj.org/article/b9240e38227148be9226cb4333c32437
Autor:
Takahiro Fukuhara, Takayuki Katsube, Kazushi Numata, Michio Imawari, Katsuaki Tanaka, Namiki Izumi, Toshimitsu Ochiai, Yukio Osaki, Takeshi Kano
Publikováno v:
Hepatology Research. 50:1141-1150
Aim Lusutrombopag is approved for thrombocytopenia in chronic liver disease patients planned to undergo invasive procedures. In previous clinical studies, lusutrombopag treatment was stopped in patients with an increase in platelet count (PC) of ≥2
Autor:
Hiroki Nishikawa, Tadashi Inuzuka, Haruhiko Takeda, Jun Nakajima, Azusa Sakamoto, Sinichiro Henmi, Tetsurou Ishikawa, Sumio Saito, Ryuichi Kita, Toru Kimura, Yukio Osaki, Yorimitsu Koshikawa
Publikováno v:
Case Reports in Oncology, Vol 4, Iss 2, Pp 327-335 (2011)
Miriplatin, a cisplatin derivative with a high affinity for iodized ethyl esters of fatty acids from poppy seed oil, is a novel chemotherapeutic agent designed for use in the transarterial treatment of hepatocellular carcinoma (HCC). Here, we describ
Externí odkaz:
https://doaj.org/article/7f11eb2c83b64d1e953112575a10ba75
Autor:
Hiroki Nishikawa, Yukio Osaki
Publikováno v:
Mediators of Inflammation, Vol 2015 (2015)
The liver is the major organ for the metabolism of three major nutrients: protein, fat, and carbohydrate. Chronic hepatitis C virus infection is the major cause of chronic liver disease. Liver cirrhosis (LC) results from different mechanisms of liver
Externí odkaz:
https://doaj.org/article/924f7a7ea1fb4ac3bf2fcf47c0b6b69c